Company Profile

Xi'an Kintai Biotech, Inc, founded in October 2012, is a national high-tech enterprise specializing in the research, development, production and sales of plant extracts, pharmaceutical intermediates and other effective ingredients of natural products.

Kintai's product supply, R&D and manufacturing center is located in the Zhongnan high-tech airport industrial park in Xixian New Area, Shaanxi. The company has modern production lines and 100000 level clean workshops that meet GMP standards, and a 600㎡ R&D pilot platform, which has independent R&D and industrialization capabilities.

Kintai's leading products are alkaloids and organic acids, including lappaconitine hydrobromide, aconitine, sanguinarine, chelerythrine, rosmarinic acid, chlorogenic acid, dihydromyricetin, mangiferin, betulin, and epimedium extract, etc. The products have successively passed the quality system and product certification such as FDA registration, ISO9001 certification, HACCP certification, Kosher certification, Halal certification, export food production enterprise filing, as well as a number of national invention patents and American invention patents for product technology.

With strong technical force, perfect quality inspection system and advanced production equipment, Kintai's health natural products have been sold well in more than twenty countries, including Europe, North America, Australia, Southeast Asia, Russia, etc., and are widely used in medicine, health food, cosmetics, food drinks, animal feed and other fields.

10years

Biotech Experience

6

Qualifications

16+

Patent certification

2+

Production base

65+

Products in stock

Development History

<
>

2012

Founded in 2012

Xi'an Kintai Biotech Inc. was established.
2014

Settled in 2014

Marketing Center was located in Xi'an Beilin Dahua Nanmen Center.
2016

Qualification certification in 2016

The company has passed KOF-KOSHER and HALAL certification.
2017

The biotech laboratory was established in 2017.

The plant extract laboratory was established in Xi’an aerospace base.
2018

Preliminary development in 2018

The production process of 98% high content rosmarinic acid was successfully developed and industrialized, which greatly reduced the production cost.
2019

Sustainable development in 2019

The production base project in Xi'an Aerospace was put into use, and the annual quantity of refined and processed plant / herbal materials exceeded 200 tons/year for the first time.
2020

High speed development in 2020

The 600㎡ R&D Center was successfully launched in Xi'an Airport Industrial Port of Zhongnan Hi tech, and the construction began in March 2020; The key technologies of the company's core products, such as high-purity dihydromyricetin, betulin and betulinic acid, have made breakthroughs and applied for national invention patents.
2021

Patent application in 2021

Mangiferin, the core product of the company, has successfully applied for the national invention patent and obtained the authorization, and the mangiferin is in the process of applying for the US invention patent.
2022

New Journey in 2022

Kintai has passed the national high-tech enterprise certification; The construction of 100000 level clean workshop has been completed; Shaanxi Kintai Healthtech Inc. a sister company of Kintai Biotech Inc, was established and settled in the Sales Center of Zhongnan Hi tech Airport Industrial Port.

<
>

Company Culture

Kintai Mission

Plant extract experts, protect human health.
Kintai Vision

Advocate nature, extract essence, lead biotechnology, and create a healthy life.
Kintai Culture

The company adheres to the development philosophy of "quality first, technology leading and innovation oriented", leading biotechnology;
The company insists on the business philosophy of being rigorous, realistic, customer first, and trustworthy to create a healthy life.

Company Profile

Development History

2012

2014

2016

2017

2018

2019

2020

2021

2022

Company Culture

Certificates

Contact information

WhatsApp Code